Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.
- Status
- TERMINATED
- Phase
- NA
A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).
- Status
- COMPLETED
- Phase
- N/A
UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Stage I Multiple Myeloma Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)
- Status
- COMPLETED
- Phase
- PHASE3
RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer Cells and Bortezomib to Treat Cancer
- Status
- COMPLETED
- Phase
- PHASE1
This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A